1. Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis 
Jacques Donnez, M.D., Ph.D., Paul J Dewart, M.D., Bernard Hedon, M.D., Antonio Perino, M.D., Adolf E Schindler, M.D., Joëlle Blumberg, M.D., Denis Querleu, M.D. 
Fertility and Sterility 
Volume 81, Issue 2, Pages (February 2004)
DOI: /j.fertnstert

2. FIGURE 1
(A) FSH, (B) LH, and (C) estradiol log linear scale plasma profiles in the two treatment groups (♦ SR 3-month; • SR 28-day).
Donnez. Decapeptyl pharmacodynamics in endometriosis. Fertil Steril 2004.
Fertility and Sterility  , DOI: ( /j.fertnstert )

3. FIGURE 2
Mean triptorelin ± SD concentration over time following a single IM injection of triptorelin 3-month SR (• Group A) and following three monthly IM injections of triptorelin 28-day SR (○ Group B).
Donnez. Decapeptyl pharmacodynamics in endometriosis. Fertil Steril 2004.
Fertility and Sterility  , DOI: ( /j.fertnstert )